Pharmacy Place, LLC
Outcome
DEA issued Order to Show Cause and Immediate Suspension November 17, 2021; revoked DEA Certificate of Registration No. FP8885785, published October 30, 2025, for filling controlled substance prescriptions from March 2020 through August 2021 with multiple unresolved red flags including pattern prescribing, cash payments, drug cocktails, and prescriptions missing required information.
Details
Pharmacy Place, LLC — DEA Immediate Suspension and Revocation for Multi-Red-Flag Dispensing (2021–2025)
Outcome: DEA issued an Order to Show Cause and Immediate Suspension of Registration on November 17, 2021, against Pharmacy Place, LLC of Houston, Texas, and revoked DEA Certificate of Registration No. FP8885785 in a Decision and Order published October 30, 2025, after finding the pharmacy filled controlled substance prescriptions with multiple simultaneous red flags of abuse and diversion from March 2020 through August 2021.
Pharmacy Place, LLC was a pharmacy in Houston, Texas. On November 17, 2021, the DEA issued an Order to Show Cause and Immediate Suspension of Registration proposing revocation based on the pharmacy's practices during March 16, 2020, through August 19, 2021.
A DEA pharmacy expert reviewed patient profile data, Texas Prescription Monitoring Program data, and prescriptions reported as filled by the pharmacy. The expert found that Pharmacy Place filled many controlled substance prescriptions outside the usual course of pharmacy practice and in contravention of its corresponding responsibility. The identified red flags encompassed multiple categories simultaneously: pattern prescribing (where the same drug combinations were repeatedly written for multiple patients in identical patterns); patient travel distances; cash payments; drug cocktail combinations (controlled substances known to be abused in combination); high doses or large quantities of high-alert controlled substances; and prescriptions that were missing required patient address or prescriber DEA number information.
After a lengthy administrative proceeding, the DEA revoked the registration. The Decision and Order was published in the Federal Register on October 30, 2025.
Primary Source: Pharmacy Place, LLC; Decision and Order (Fed. Reg. Oct. 30, 2025)
How Crucible Prevents This
Pharmacy Place filled prescriptions missing both the patient's address and the prescriber's DEA number — minimum legal requirements for a valid controlled substance prescription. Crucible's prescription validation controls would reject any controlled substance prescription missing these mandatory fields before it enters the dispensing workflow.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works